J Korean Med Sci.  2010 Jul;25(7):1011-1016. 10.3346/jkms.2010.25.7.1011.

Descriptive Epidemiology of Cholangiocarcinoma and Clonorchiasis in Korea

• Shin HR
• Oh JK
• Lim MK
• Shin A
• Kong HJ
• Jung KW
• Won YJ
• Park S
• Park SJ
• Hong ST

• KMID: 1792949
• DOI: http://doi.org/10.3346/jkms.2010.25.7.1011

Abstract

In 2009, infection with the liver fluke Clonorchis sinensis (C. sinensis) was classified as "carcinogenic to humans" (Group 1) based on its involvement in the etiology of cholangiocarcinoma by the International Agency for Research on Cancer. However, little is known about the descriptive epidemiology of cholangiocarcinoma in Korea. We examined incidence trends of intrahepatic and extrahepatic cholangiocarcinomas, using data from the Korea National Cancer Incidence database for 1999-2005. The prevalence of C. sinensis infection was estimated from a recent population-based survey in rural endemic areas. Cholangiocarcinoma incidence rates are currently rising, even while primary liver cancer incidence rates are decreasing. Annual percent changes in cholangiocarcinoma incidence rates were 8% for males and 11% in females. Known areas of C. sinensis endemicity showed high incidence rates of cholangiocarcinoma. The positivity of C. sinensis eggs in stool samples from endemic areas was more than 25% of adults tested during 2005-2008. From a meta-analysis, the summary odds ratio for cholangiocarcinoma due to C. sinensis infection was 4.7 (95% confidence interval: 2.2-9.8). Approximately 10% of cholangiocarcinomas in Korea were caused by chronic C. sinensis infections. More specific policies, including health education and an extensive effort for early detection in endemic areas, are needed.

Keyword

cholangiocarcinoma; Clonorchis sinensis; Korea

MeSH Terms

Adult
Aged
Aged, 80 and over
Animals
Bile Duct Neoplasms/*epidemiology/parasitology
Bile Ducts, Intrahepatic/parasitology/*pathology
Cholangiocarcinoma/*epidemiology/parasitology
Clonorchiasis/*epidemiology
Female
Humans
Korea/epidemiology
Male
Middle Aged

Figure

• 

  Fig. 1 Age specific incidence rates of cholangiocarcinoma by sex for 1999-2000 and 2003-2005. (A) Intrahepatic, (B) Extrahepatic.

• 

  Fig. 2 Risk estimates for cholangiocarcinoma according to Clonorchis sinensis infection status.

Reference

1. Kaewkes S. Taxonomy and biology of liver flukes. Acta Tropica. 2003. 88:177–186.

2. Lun ZR, Gasser RB, Lai DH, Li AX, Zhu XQ, Yu XB, Fang YY. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis. 2005. 5:31–41.

3. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobactor pylori. IARC monographs on the evaluation of carcinogenic risks to humans. 1994. vol. 61. Lyon France: International Agency for Research on Cancer.

4. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. A review of human carcinogens-Part B: biological agents. Lancet Oncol. 2009. 10:321–322.

5. Lim MK, Ju YH, Franceschi S, Oh JK, Kong HJ, Hwang SS, Park SK, Cho SI, Sohn WM, Kim DI, Yoo KY, Hong ST, Shin HR. Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg. 2006. 75:93–96.

6. Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, Ahn YO, Shigemastu T. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol. 1996. 25:933–940.

7. Choi D, Lim JH, Lee KT, Lee JK, Choi SH, Heo JS, Jang KT, Lee NY, Kim S, Hong ST. Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea. J Hepatol. 2006. 44:1066–1073.

8. Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, Kwon S, Lee SK, Seo DW, Kim MH, Suh DJ. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol. 2008. 103:1716–1720.

9. Kim YI, Yang DH, Chang KR. Relationship between Clonorchis sinensis infestation and cholangiocarcinoma of the liver in Korea. Seoul J Med. 1974. 15:247–253. (in Korean).

10. Chung CS, Lee SK. An epidemiological study of primary liver carcinomas in Busan area with special reference to clonorchis. Korean J Pathol. 1976. 10:33–46.

11. World Health Organization. International Classification of Diseases. 1992. vol. 10. Geneva: World Health Organization.

12. Fritz A, Percy C, Jack A, Shanmugaratnam K, Parkin M. International classification of diseases for oncology (ICD-O). 2000. 3rd ed. Geneva, Switzerland: World Health Organization.

13. Shin HR, Won YJ, Jung KW, Park JG, Hong EK, Suh CI, Lee SY, Kim KY, Seo SW, Lee JK. Cancer Incidence in Korea (1999-2002). Cancer Incidence in Five Continents. 2007. Volume IX. Lyon: International Agency for Research on Cancer.

14. Won YJ, Sung J, Jung KW, Kong HJ, Park SK, Shin HR, Park EC, Ahn YO, Hwang IK, Lee DH, Choi JS, Kim WC, Lee TY, Yoo CI, Bae JM, Kim ON, Park IS, Kong IS, Lee DH, Lee JS. Nationwide Cancer Incidence in Korea, 2003-2005. Cancer Res Treat. 2009. 41:122–131.

15. Kim TS, Cho SH, Huh S, Kong Y, Sohn WM, Hwang SS, Chai JY, Lee SH, Park YK, Oh DK, Lee JK. A nationwide survey on the prevalence of intestinal parasitic infections in the Republic of Korea, 2004. Korean J Parasitol. 2009. 47:37–47.

16. McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2006. 15:1198–1203.

17. West J, Wood H, Logan RF, Quinn M, Aithal GP. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Brit J Cancer. 2006. 94:1751–1758.

18. Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006. 98:873–875.

19. Rim HJ. Clonorchiasis: an update. J Helminthol. 2005. 79:269–281.

20. Blechacz BR, Gores GJ. Cholangiocarcinoma. Clin Liver Dis. 2008. 12:131–150.

21. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 2008. 10:77–82.

22. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med. 1999. 341:1368–1378.

23. Okuda K, Nakanuma Y, Miyazaki M. Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology. J Gastroenterol Hepatol. 2002. 17:1049–1055.

24. Chen MF, Jan YY, Jeng LB, Hwang TL, Wang CS, Chen SC, Chao TC, Chen HM, Lee WC, Yeh TS, Lo YF. Intrahepatic cholangiocarcinoma in Taiwan. J Hepatobiliary Pancreat Surg. 1999. 6:136–141.

25. Kubo S, Kinoshita H, Hirohashi K, Hamba H. Hepatolithiasis associated with cholangiocarcinoma. World J Surg. 1995. 19:637–641.

26. Kim YT, Byun JS, Kim J, Jang YH, Lee WJ, Ryu JK, Kim SW, Yoon YB, Kim CY. Factors predicting concurrent cholangiocarcinomas associated withhepatolithiasis. Hepatogastroenterology. 2003. 50:8–12.